Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
78.00
-408.00
-682.00
-657.00
-535.00
-347.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-143.00
-10.00
111.00
-12.00
-32.00
89.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
209.00
-92.00
-357.00
-440.00
-253.00
-42.00
Cash Flow from Investing Activities
-148.00
-110.00
-178.00
-101.00
-211.00
-458.00
Cash Flow from Financing Activities
-78.00
-31.00
705.00
264.00
975.00
555.00
Net Cash Inflow / Outflow
-14.00
-230.00
186.00
-278.00
506.00
53.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
3.00
16.00
0.00
-4.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
78.815483783174
691.94623516711
-613.00
-88.61%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-143.176095298079
-105.903732264305
-38.00
-35.19%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
209.359287092234
632.742192247156
-423.00
-66.91%
Cash Flow from Investing Activities
-148.663352164994
-774.965254787674
626.00
80.82%
Cash Flow from Financing Activities
-78.6441764160583
60.2459820326008
-138.00
-230.54%
Net Cash Inflow / Outflow
-14.9698785934586
-80.646737853164
66.00
81.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.97836289535965
1.33034265475293
1.00
123.88%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 325.70% vs 74.04% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
209.36
-92.76
325.70%






